Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
作者： Xavier Fradera , Erin F DiMauro , Joey L Methot , Samuel M Levi , Abdelghani Achab
DOI: 10.1021/ACSMEDCHEMLETT.1C00096
关键词:
摘要: … and other structural classes examined as HPK1 inhibitors was a distinct “bell-shaped” IL-… HPK1 inhibitor titration. While a sigmoidal or “sustained” IL-2 response curve to HPK1 inhibitor …
acs.org
sci-hub.st 参考文章(41)
Saba Alzabin, Nina Bhardwaj, Friedemann Kiefer, Sansana Sawasdikosol, Steven Burakoff, Hematopoietic Progenitor Kinase 1 Is a Negative Regulator of Dendritic Cell Activation Journal of Immunology. ,vol. 182, pp. 6187- 6194 ,(2009) , 10.4049/JIMMUNOL.0802631
Antoni Ribas, Igor Puzanov, Reinhard Dummer, Dirk Schadendorf, Omid Hamid, Caroline Robert, F Stephen Hodi, Jacob Schachter, Anna C Pavlick, Karl D Lewis, Lee D Cranmer, Christian U Blank, Steven J O'Day, Paolo A Ascierto, April K S Salama, Kim A Margolin, Carmen Loquai, Thomas K Eigentler, Tara C Gangadhar, Matteo S Carlino, Sanjiv S Agarwala, Stergios J Moschos, Jeffrey A Sosman, Simone M Goldinger, Ronnie Shapira-Frommer, Rene Gonzalez, John M Kirkwood, Jedd D Wolchok, Alexander Eggermont, Xiaoyun Nicole Li, Wei Zhou, Adriane M Zernhelt, Joy Lis, Scot Ebbinghaus, S Peter Kang, Adil Daud, Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial The Lancet Oncology. ,vol. 16, pp. 908- 918 ,(2015) , 10.1016/S1470-2045(15)00083-2
M C Hu, W R Qiu, X Wang, C F Meyer, T H Tan, Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes & Development. ,vol. 10, pp. 2251- 2264 ,(1996) , 10.1101/GAD.10.18.2251
Ramadevi Sanam, S Vadivelan, Sunita Tajne, Lakshmi Narasu, G Rambabu, Sarma ARP Jagarlapudi, None, Discovery of potential ZAP-70 kinase inhibitors: pharmacophore design, database screening and docking studies European Journal of Medicinal Chemistry. ,vol. 44, pp. 4793- 4800 ,(2009) , 10.1016/J.EJMECH.2009.07.018
Lynette A. Smyth, Ian Collins, Measuring and interpreting the selectivity of protein kinase inhibitors Journal of Chemical Biology. ,vol. 2, pp. 131- 151 ,(2009) , 10.1007/S12154-009-0023-9
Ira Mellman, George Coukos, Glenn Dranoff, Cancer immunotherapy comes of age Nature. ,vol. 480, pp. 480- 489 ,(2011) , 10.1038/NATURE10673
Jr-Wen Shui, Jonathan S Boomer, Jin Han, Jun Xu, Gregory A Dement, Guisheng Zhou, Tse-Hua Tan, Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses. Nature Immunology. ,vol. 8, pp. 84- 91 ,(2007) , 10.1038/NI1416
Sansana Sawasdikosol, Saiju Pyarajan, Saba Alzabin, Gabriel Matejovic, Steven J. Burakoff, Prostaglandin E2Activates HPK1 Kinase Activity via a PKA-dependent Pathway Journal of Biological Chemistry. ,vol. 282, pp. 34693- 34699 ,(2007) , 10.1074/JBC.M707425200
Daniel L Barber, E John Wherry, David Masopust, Baogong Zhu, James P Allison, Arlene H Sharpe, Gordon J Freeman, Rafi Ahmed, None, Restoring function in exhausted CD8 T cells during chronic viral infection Nature. ,vol. 439, pp. 682- 687 ,(2006) , 10.1038/NATURE04444
F. Stephen Hodi, Steven J. O'Day, David F. McDermott, Robert W. Weber, Jeffrey A. Sosman, John B. Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J.M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M. Vaubel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael J. Yellin, Geoffrey M. Nichol, Axel Hoos, Walter J. Urba, Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. The New England Journal of Medicine. ,vol. 363, pp. 711- 723 ,(2010) , 10.1056/NEJMOA1003466